Epilepsy and Cannabis: A Literature Review
Abstract Epilepsy is considered to be one of the most common non-communicable neurological diseases especially in low to middle-income countries....
Endocannabinoid System and Migraine Pain: An Update
Apr 21, 2021
The trigeminovascular system (TS) activation and the vasoactive release from trigeminal endings, in proximity of the meningeal vessels, are considered...
Species-specific susceptibility to cannabis-induced convulsions
Apr 21, 2021
BACKGROUND AND PURPOSE Numerous claims are made for cannabis’ therapeutic utility upon human seizures, but concerns persist about risks. A...
Cannabis for COVID-19: can cannabinoids quell the cytokine storm?
Apr 21, 2021
The recent emergence of SARS coronavirus 2 (SARS-CoV-2) has resulted in the alarming spread of the highly infectious and contagious COVID-19...
Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
Apr 21, 2021
Abstract Cannabis sativa and its extracts have been used for centuries, both medicinally and recreationally. There is accumulating evidence that...
Anti-Inflammatory Activity in Colon Models Is Derived from D9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts
Apr 20, 2021
Abstract Introduction: Inflammatory bowel diseases (IBDs) include Crohn’s disease, and ulcerative colitis. Cannabis sativa preparations have beneficial effects for IBD patients. However, C. sativa extracts...
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
Apr 20, 2021
Abstract Cannabis sativa and its extracts have been used for centuries, both medicinally and recreationally. There is accumulating evidence that exogenous...
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects
Apr 20, 2021
Abstract There is now a large body of data that indicates that the CB2 cannabinoid receptor type 2 (CB2) is linked...
The role of cannabinoids in dermatology
Apr 20, 2021
T wenty-eight states currently allow for comprehensive public medical cannabis programs, and this number continues to grow.1 Approximately 1 in...
Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system
Apr 20, 2021
Abstract Aim Acute myocardial infarction and subsequent post-infarction heart failure are among the leading causes of mortality worldwide. The endocannabinoid...
Search Our Website
Recent In The News
- CBD Oracle Interviews VCS Board and Sponsors
- New York Times: Mammals with the Munchies
- Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
- BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
- Cannabis in Veterinary Medicine | Continual Education | VIN
- Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
- A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
- Earth Buddy, Pet Calming Study – Press Release
- CALIFORNIA CANNABIS UPDATES – April 2022
- Cannabis in Veterinary Practice Multi-Expert Webinar